Related references
Note: Only part of the references are listed.FcγRI and FcγRIII on splenic macrophages mediate phagocytosis of anti-glycoprotein IIb/IIIa autoantibody-opsonized platelets in immune thrombocytopenia
Peter A. A. Norris et al.
HAEMATOLOGICA (2021)
IgG-Fc glycosylation before and after rituximab treatment in immune thrombocytopenia
David E. Schmidt et al.
SCIENTIFIC REPORTS (2020)
A stable engineered human IgG3 antibody with decreased aggregation during antibody expression and low pH stress
Seiji Saito et al.
PROTEIN SCIENCE (2019)
Role of Platelet Glycoprotein VI and Tyrosine Kinase Syk in Thrombus Formation on Collagen-Like Surfaces
Natalie J. Jooss et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Treating murine inflammatory diseases with an anti-erythrocyte antibody
Andrew R. Crow et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Potential Anti-Thrombotic Effect without Accompanying Hemorrhage with Fostamatinib Use in Patients with Immune Thrombocytopenia
Ivy Altomare et al.
BLOOD (2019)
Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo-controlled trials
James Bussel et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Pathophysiology of immune thrombocytopenia
June Li et al.
CURRENT OPINION IN HEMATOLOGY (2018)
Decoding the Human Immunoglobulin G-Glycan Repertoire Reveals a Spectrum of Fc-Receptor- and Complement-Mediated-Effector Activities
Gillian Dekkers et al.
FRONTIERS IN IMMUNOLOGY (2017)
Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP)
Anne Zufferey et al.
JOURNAL OF CLINICAL MEDICINE (2017)
Monovalent Fc receptor blockade by an anti-Fcγ receptor/albumin fusion protein ameliorates murine ITP with abrogated toxicity
Xiaojie Yu et al.
BLOOD (2016)
CD44 Antibody Inhibition of Macrophage Phagocytosis Targets Fcγ Receptor- and Complement Receptor 3-Dependent Mechanisms
Alaa Amash et al.
JOURNAL OF IMMUNOLOGY (2016)
FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis
Rony Dahan et al.
CANCER CELL (2015)
Mouse and human FcR effector functions
Pierre Bruhns et al.
IMMUNOLOGICAL REVIEWS (2015)
The role of isoagglutinins in intravenous immunoglobulin-related hemolysis
Caroline L. Bellac et al.
TRANSFUSION (2015)
C-reactive protein enhances IgG-mediated phagocyte responses and thrombocytopenia
Rick Kapur et al.
BLOOD (2015)
Anti-CD44 Antibody Treatment Lowers Hyperglycemia and Improves Insulin Resistance, Adipose Inflammation, and Hepatic Steatosis in Diet-Induced Obese Mice
Keiichi Kodama et al.
DIABETES (2015)
CD44 antibody-mediated amelioration of murine immune thrombocytopenia (ITP): mouse background determines the effect of FcRIIb genetic disruption
Andrew R. Crow et al.
TRANSFUSION (2015)
IgG subclasses and allotypes: from structure to effector functions
Gestur Vidarsson et al.
FRONTIERS IN IMMUNOLOGY (2014)
CD44 Antibodies and Immune Thrombocytopenia in the Amelioration of Murine Inflammatory Arthritis
Patrick J. Mott et al.
PLOS ONE (2013)
Pathogenic and regulatory roles for B cells in experimental autoimmune encephalomyelitis
Monica K. Mann et al.
AUTOIMMUNITY (2012)
The neonatal Fc receptor (FcRn) is not required for IVIg or anti-CD44 monoclonal antibody-mediated amelioration of murine immune thrombocytopenia
Andrew R. Crow et al.
BLOOD (2011)
Mouse and human neutrophils induce anaphylaxis
Friederike Joensson et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
PF-03475952: a Potent and Neutralizing Fully Human Anti-CD44 Antibody for Therapeutic Applications in Inflammatory Diseases
Herbert A. Runnels et al.
ADVANCES IN THERAPY (2010)
Animal models of immune thrombocytopenia (ITP)
John W. Semple
ANNALS OF HEMATOLOGY (2010)
The SYK tyrosine kinase: a crucial player in diverse biological functions
Attila Mocsai et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk
Anna Podolanczuk et al.
BLOOD (2009)
Specificity and affinity of human Fcγ receptors and their polymorphic variants for human IgG subclasses
Pierre Bruhns et al.
BLOOD (2009)
3G8 and GMA161, Anti FcγRIII Inhibitory Monoclonal Antibodies in the Treatment of Chronic Refractory ITP. (Summary of 2 Pilot Studies)
Charles T. Nakar et al.
BLOOD (2009)
CD44-specific antibody treatment and CD44 deficiency exert distinct effects on leukocyte recruitment in experimental arthritis
Gabor Hutas et al.
BLOOD (2008)
Proposed relationship between intravenous immunoglobulin and thrombosis in renal transplant recipients
Antoinette Duronio et al.
ANNALS OF PHARMACOTHERAPY (2007)
A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2
K Suzuki-Inoue et al.
BLOOD (2006)
FcγRIV:: A novel FcR with distinct IgG subclass specificity
F Nimmerjahn et al.
IMMUNITY (2005)
Mouse B cell activation is inhibited by CD44 cross-linking
TL Wyant et al.
IMMUNOLOGICAL INVESTIGATIONS (2005)
Review: intravenous immunoglobulin therapy and thromboembolic complications
U Katz et al.
LUPUS (2005)
Monoclonal IgG can ameliorate immune thrombocytopenia in a murine model of ITP: an alternative to IVIG
S Song et al.
BLOOD (2003)
Essential role of Fcγ receptors in anti-type II collagen antibody-induced arthritis
T Kagari et al.
JOURNAL OF IMMUNOLOGY (2003)
Osteopontin is involved in the initiation of cutaneous contact hypersensitivity by inducing langerhans and dendritic cell migration to lymph nodes
JM Weiss et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Therapeutic efficacy of intravenous immunoglobulin preparations depends on the immunoglobulin G dimers: studies in experimental immune thrombocytopenia
JL Teeling et al.
BLOOD (2001)
Induction of resistance to diabetes in non-obese diabetic mice by targeting CD44 with a specific monoclonal antibody
L Weiss et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
